Cancer and family history
Breast or ovarian cancer in the family: questions to take to your doctor
My mother has breast cancer. My aunt had ovarian cancer. Are these connected? These are reasonable questions for a healthcare conversation, but a shared family name or a familiar gene name cannot answer them on its own.
Start with the diagnosis you know. Breast cancer, ovarian cancer and a cancer described simply as gynaecological are not interchangeable. Keeping the original wording makes it easier to ask the right follow-up question.
Include relatives on both sides
An inherited susceptibility can come through either biological parent. Breast cancer in a male relative also belongs in the history. Do not leave out your father's family because the concern involves breast or ovarian cancer.
For your notes, give each relative a separate line. Mark the approximate age, whether there were different primary cancers and which facts come from a document. If an aunt's diagnosis is uncertain, keep that uncertainty visible.
What BRCA means—and does not mean
Everyone has BRCA1 and BRCA2 genes. Certain harmful variants in them can increase susceptibility to particular cancers. Other genes are relevant in some settings: PALB2 in breast cancer, and BRIP1, RAD51C and RAD51D in ovarian cancer discussions.
These names are background vocabulary, not a recommended panel or evidence of a variant in your family. A professional needs the exact diagnosis and context. An ovarian, fallopian-tube or primary-peritoneal diagnosis should be clarified from the original record.
Ask what a consultation could change
A genetics conversation can explore whether testing would be informative, whose result would be most useful and what different outcomes could mean. You can also ask about emotional support and how to discuss decisions with relatives.
Before the appointment, choose two priorities: for example, understanding your mother's report and learning who should advise you about your own follow-up. Bring those questions even if the family has not gathered every record.
Do not confuse treatment testing with inheritance
A tumour result used by an oncology team is not the same as confirmation of an inherited variant. Ask the team whether a report addresses treatment, inherited susceptibility, or both, and who should explain it to relatives.
This article cannot choose breast imaging, ovarian surveillance or preventive treatment for you. Ask your clinician for a plan suited to your situation and country. Genidi's educational journey can organise questions but cannot replace that decision.
What to prepare for the conversation
- Confirm breast, ovarian or another specific diagnosis without guessing.
- Include relevant relatives from both biological family branches.
- Ask whether an existing report is tumour testing or germline testing.
- Ask what a positive, negative or uncertain result would mean.
- Write down who will advise you about personal follow-up.
Common questions
Does breast cancer in my father's family count?
Yes. Include that family branch in the conversation. The path through a father does not exclude inherited susceptibility.
Does a BRCA name in a report mean I have that variant?
No. The gene name alone is insufficient. The exact variant, classification, type of test and person tested need professional interpretation.
Should I book a genetic test before a consultation?
This guide cannot recommend a test. Ask a qualified professional whether testing would help answer your question and which family information should be reviewed first.
Sources and editorial review
Sources checked on 5 September 2026. Educational content prepared by Genidi; not yet reviewed by an independent clinician.